Clara Burtenshaw is a co-founder and partner at Neo Kuma Ventures, Europe’s first psychedelic healthcare focussed VC fund. She serves as a Board Advisor to the International Therapeutic Psilocybin Rescheduling Initiative and was named one of Business Insider’s most influential women in Psychedelics.
Clara collaborates closely with policy makers, scientists, academics, and media to explore how psychedelics and novel therapeutics derived from them can be integrated into primary and secondary healthcare, and has spoken internationally on the topic. Neo Kuma’s thought leadership pieces have been published in Fortune, Investment Week, Business Insider and a variety of national press in the United Kingdom.
Clara began her career at a leading law firm and received degrees from Oxford University and NYU School of Law.
Clara collaborates closely with policy makers, scientists, academics, and media to explore how psychedelics and novel therapeutics derived from them can be integrated into primary and secondary healthcare, and has spoken internationally on the topic. Neo Kuma’s thought leadership pieces have been published in Fortune, Investment Week, Business Insider and a variety of national press in the United Kingdom.
Clara began her career at a leading law firm and received degrees from Oxford University and NYU School of Law.
Speaking In
9:00 AM - 10:00 AM (PDT)
Thursday, June 16
The psychedelics industry has evolved from a stigmatized counterculture phenomenon to a…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
